Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ARENA PHARMACEUTICALS, INC
06/19 ARENA PHARMACEUTICALS, INC. : REVERSE SPLIT: 1 for 10
06/15 ARENA PHARMACEUTICALS : to Present at JMP Securities Life Sciences Conference
06/14 ARENA PHARMACEUTICALS : Announces Shareholders and Board of Directors Approve Re..
06/14 ARENA PHARMACEUTICALS : Appoints Jennifer Jarrett to Board of Directors
06/01 ARENA PHARMACEUTICALS : to Present at the Jefferies 2017 Global Healthcare Confe..
05/18 ARENA PHARMACEUTICALS : to Host Key Opinion Leader Event on Pulmonary Arterial H..
05/16 ARENA PHARMACEUTICALS : to Present Phase 1 Data on Ralinepag for Treatment of Pu..
05/15 INSIDER TRADING ACTIVITY ARENA PHARM : ARNA) – Insider Bought 25,000 share..
05/10 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) reported earnings of ($0.09) per sha..
05/09 ARENA PHARMACEUTICALS : reports 1Q loss
05/09 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports First Quarter 2017..
05/02 ARENA PHARMACEUTICALS : to Release First Quarter 2017 Financial Results and Prov..
04/27 INSIDER TRADING ACTIVITY ARENA PHARM : ARNA) – Insider Bought 50,000 share..
04/21 ARENA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stock ..
04/18 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Other Events
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
06/19 ARENA PHARMACEUTICALS, INC. : REVERSE SPLIT: 1 for 10
06/15 ARENA PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K/A)
06/15 ARENA PHARMACEUTICALS INC : Change in Directors or Principal Officers, Amendment..
06/15 ARENA PHARMACEUTICALS : to Present at JMP Securities Life Sciences Conference
06/14 ARENA PHARMACEUTICALS : Announces Shareholders and Board of Directors Approve Re..
06/14 ARENA PHARMACEUTICALS : Appoints Jennifer Jarrett to Board of Directors
06/01 ARENA PHARMACEUTICALS : to Present at the Jefferies 2017 Global Healthcare Confe..
05/25 ARENA PHARMACEUTICALS : to Host Key Opinion Leader Event on Pulmonary Arterial H..
05/25 ARENA PHARMACEUTICALS : to Present Phase 1 Data on Ralinepag for Treatment of Pu..
05/22 ARENA PHARMACEUTICALS, INC. : Today's Research Reports on Biotech Stocks to Watc..
More news
Sector news : Biotechnology & Medical Research - NEC
06/21 Healthcare stocks rally as Senate set to unveil bill
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
06/14 JOHNSON & JOHNSON : flu drug succeeds in mid-stage trial
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/21 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi Presents at JMP Securities Life..
06/20 Arena continues up move, shares ahead 25% in three days
06/19 DRYSHIPS : Rank #1 As Worst Stock In Nasdaq
06/17 Stocks to watch next week
06/15 PREMARKET LOSERS AS OF 9 : 05 am
06/15 Arena Announces 1-For-10 Reverse Stock Split
Latest Tweets
06/21$ARNA going for 17 
06/21Cantor Fitzgerald Comments on Arena Pharmaceuticals, Inc.’s FY2017 Earnings $.. 
06/21$ARNA still going 
06/21Cantor Fitzgerald Initiates Coverage on Arena Pharmaceuticals, Inc. $ARNA  
06/20$ARNA for bounce 
More tweets
Qtime:35
Advertisement
Financials ($)
Sales 2017 22,7 M
EBIT 2017 -80,6 M
Net income 2017 -86,2 M
Finance 2017 29,3 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 21,9x
EV / Sales 2018 21,8x
Capitalization 527 M
More Financials
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Full-screen chart
Technical analysis trends ARENA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 35,5 $
Spread / Average Target 114%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS,..16.90%500
INCYTE CORPORATION33.63%25 511
QUINTILES IMS HOLDINGS..18.05%19 076
LONZA GROUP25.04%15 596
CELLTRION, INC.--.--%12 276
SEATTLE GENETICS, INC.20.28%8 821
More Results